Why DermTech Stock Jumped Today
Shares of DermTech (NASDAQ: DMTK) were moving higher today after the biotech announced an agreement with Blue Cross Blue Shield of Texas (BCBSTX) to make the company's Pigmented Legion Assay (PLA) available to the insurer's approximately 6 million members in that state.
The stock was up 23.6% as of 12:13 p.m. EST on Thursday as a result.
The DermTech PLA patch. Image source: DermTech.
Source Fool.com


